Aspirin-Sensitive Asthma With Nasal Polyps Clinical Trial
Official title:
Mechanisms of Alcohol Sensitivity in Aspirin Exacerbated Respiratory Disease
NCT number | NCT03441438 |
Other study ID # | 20382 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 1, 2018 |
Est. completion date | September 1, 2018 |
The purpose of this study is to determine what type of reactions in the body may be responsible for the respiratory symptoms that occur when patients with Aspirin Exacerbated Respiratory Disease (AERD) drink alcoholic beverages. These reactions are most often seen with red wine.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | September 1, 2018 |
Est. primary completion date | September 1, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - Healthy Controls - must be 21 years or older - Aspirin Tolerant Asthma and AERD arms must note a sensitivity to alcoholic beverages Exclusion Criteria: - Enzymopathies - Mastocytosis - Alcoholism - Prior severe respiratory reaction to alcohol consumption - Current pregnancy - Monoamine Oxidase Inhibitor (MAOI) use - Age under 21 - Use of leukotriene modifier 1 week before study intervention - Having undergone and maintained aspirin desensitization |
Country | Name | City | State |
---|---|---|---|
United States | University of Virginia | Charlottesville | Virginia |
Lead Sponsor | Collaborator |
---|---|
University of Virginia |
United States,
Cardet JC, White AA, Barrett NA, Feldweg AM, Wickner PG, Savage J, Bhattacharyya N, Laidlaw TM. Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):208-13.. doi: 10.1016/j.jaip.2013.12.003. — View Citation
Payne SC. Re: Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):644. doi: 10.1016/j.jaip.2014.05.003. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 24 Hour Urinary Leukotriene-E4 (LTE4) | Urine LTE4 ng/mg Cr | 24 hour | |
Secondary | 24 Hour Urinary Prostaglandin-D2 (PGD2) metabolite | Urine PGD2 metabolite ng/mg Cr | 24 hour collection | |
Secondary | Whole blood Activated Basophil Level | Proportion of activated basophils in whole blood after ingestion | 2 hours after ingestion | |
Secondary | Whole Blood Activated Eosinophil Level | Proportion of activated eosinophils in whole blood after ingestion | 2 hours after ingestion | |
Secondary | Whole Blood tryptase | Level of tryptase concentration in whole blood | 2 hours after ingestion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03973749 -
Effects of a High or Low Salycilate Diet on Urinary LTE4 and Clinical Features in AERD
|
N/A | |
Withdrawn |
NCT01615536 -
The Role of Canine Fossa Trephination in the Severely Diseased Maxillary Sinus
|
N/A | |
Recruiting |
NCT05575037 -
Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
|
Phase 2 | |
Completed |
NCT03326063 -
Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban
|
Phase 2 |